The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Dachs, G U ^a   Stratford, I J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Erythropoietin; Gene therapy; Hypoxia; Hypoxia inducible factor 1; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GROWTH FACTOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRANSCRIPTION FACTOR; VASCULOTROPIN; DNA BINDING PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYMPHOKINE; NUCLEAR PROTEIN; VASCULOTROPIN A;

CANCER THERAPY; CELL DAMAGE; CELL HYPOXIA; CELL PROLIFERATION; CONFERENCE PAPER; DNA FLANKING REGION; DNA SEQUENCE; GENE EXPRESSION; GENE THERAPY; HOMEOSTASIS; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; DNA REPAIR; GENETICS; HUMAN; NEOPLASM; REVIEW;

ANIMALS; CELL HYPOXIA; CYTOKINES; DNA REPAIR; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ERYTHROPOIETIN; GENE THERAPY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; NEOPLASMS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029976685     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. AUSSERER WA, BOURRAT-FLOECK B, GREEN CJ, LADEROUTE KR AND SUTHERLAND RM. (1994). Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell. Biol., 14, 5032-5042.
2. BALLA J, NATH KA, BALLA G, JUCKETT MB, JACOB HS AND VERCELLOTTI GM. (1995). Endothelial cell heme oxygenase and ferritin induction in rat lung by haemoglobin in vivo. Am. J. Physiol., 12, L321-L327.
3. BECK I, WEINMANN R AND CARO J. (1993). Characterisation of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-kD nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood, 82, 704-711.
4. BENJAMIN IJ, KROEGER B AND WILLIAMS RS. (1990). Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc. Natl Acad. Sci. USA, 87, 6263-6267.
5. BICKNELL R AND HARRIS AL. (1991). Novel growth regulatory factors and tumour angiogenesis. Eur. J. Cancer, 27, 785-789.
6. BINIENDA Z AND SCALLET AC. (1994). The effects of reduced perfusion and reperfusion on c-fos and HSP-72 protein immunohistochemistry in gestational day 21 rat brains. Int. J. Dev. Neuroscience, 12, 605-610.
7. COLOTTA F, POLENTARUTTI N, STAFFICO M, FINCATO G AND MANTOVANI A. (1990). Heat shock induces the transcriptional activation of the c-fos proto-oncogene. Biochem. Biophys. Res. Commun., 168, 1013-1019.
8. DACHS G, PATTERSON A, TOWNSEND S, ADAMS G, FIRTH J, RATCLIFFE P, HARRIS A AND STRATFORD I. (1995). Testing hypoxia responsive elements for their use in cancer therapy. Proceedings of the 86th Annual Meeting of the AACR, 36, 421.
9. DISALVO J, BAYNE ML, CONN G, KWOK PW, TRIVEDI PG, SODERMAN DD, PALISI TM, SULLIVAN KA AND THOMAS KA. (1995). Purification and characterisation of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer. J. Biol. Chem., 270, 7717-7723.
10. FANDREY J, FREDE S AND JELKMANN W. (1994). Role of hydrogen peroxide in hypoxia induced erythropoietin production. Biochem. J., 303, 507-510.
11. FINKENZELLER G, TECHNAU A AND MARME D. (1995). Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun., 208, 432-439.
12. FIRTH JD, EBERT BL, PUGH CW AND RATCLIFFE PJ. (1994). Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with erythropoietin 3′ enhancer. Proc. Natl Acad. Sci. USA, 91, 6496-6500.
13. GALSON DL, TSUCHIYA T, TENDLER DS, HUANG LE, REN Y, OGURA T AND BUNN HF. (1995). The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonised by EAR3/COUP-TF1. Mol. Cell. Biol., 15, 2135-2144.
14. GIACCIA AJ, AUGER EA, KOONG A, TERRIS DJ, MINCHINTON AI, HAHN GM AND BROWN JM. (1992). Activation of the heat shock transcription factor by hypoxia in normal and tumour cells in vivo and in vitro. Int. J. Rad. Oncol. Biol. Phys., 23, 891-897.
15. GLEADLE JM, EBERT BL, FIRTH JD AND RATCLIFFE PJ. (1995). Regulation of angiogenic growth factor expression by hypoxia, transition metals and chelating agents. Am. J. Physiol., 37, C1362-C1368.
16. GOLDBERG MA AND SCHNEIDER TJ. (1994). Similarities between the oxygen-sensing mechanism regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem., 269, 4355-4359.
17. GOLDBERG MA, DUNNING SP AND BUNN HF. (1988). Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science, 242, 1412-1415.
18. GOLDBERG MA, GLASS GA, CUNNINGHAM JW AND BUNN HF. (1987). The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl Acad. Sci. USA, 84, 7972-7976.
19. GOLDBERG MA, GAUT CC AND BUNN HF. (1991). Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood, 77, 271.
20. GRAEBER TG, PETERSON JF, TSAI M, MONICA K, FORNACE AJ AND GIACCIA AJ. (1994). Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14, 6264-6277.
21. GRAVEN KK, TROXLER RF, KORNFELD H, PANCHENKO MV AND FARBER HW. (1994). Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J. Biol. Chem., 269, 24446-24453.
22. GUSTAFSON DL AND PRITSOS CA. (1992). Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumours. J. Natl Cancer Inst., 84, 1180-1185.
23. HALL EJ. (1988). Radiobiology for the Radiologist, 3rd edn. JB Lippinot: Philadelphia.
24. HARRISON L, ASCIONE AG, WILSON DM AND DEMPLE B. (1995). Characterization of the promoter region of the human apurinic endonuclease gene (APE). J. Biol. Chem., 270, 5556-5564.
25. HASAN NM, CUNDALL RB AND ADAMS GE. (1991). Effects of hypoxia and reoxygenation on the conversion of xanthine dehydrogenase to oxidase in chinese hamster V79 cells. Free Rad. Biol. Med., 11, 179-185.
26. HASSOUN PM, YU FS, SHEDD AL, ZULUETA JJ, THANNICKAL VJ, LANZILLO JJ AND FANBURG BL. (1994). Regulation of endothelial-cell xanthine dehydrogenase, xanthine oxidase gene expression by oxygen tension. Am. J. Physiol., 266, L163-L171.
27. HEACOCK CS AND SUTHERLAND RM. (1986). Induction characteristics of oxygen regulated proteins. Int. J. Radiation Oncology Biol. Phys., 12, 1287-1290.
28. HWANG SM, WILSON PD, LASKIN JD AND DENHARDT DT. (1994). Age and development related changes in osteopontin and nitric oxide synthase messenger RNA levels in human kidney proximal tubule epithelial cells - contrasting responses to hypoxia and reoxygenation. J. Cell. Physiol., 160, 61-68.
29. JOANNIDIS M, CANTLEY LG, SPOKES K, MEDINA R, PULLMAN J, ROSEN S AND EPSTEIN FH. (1995). Induction of heat shock proteins does not prevent renal tubular injury following ischemia. Kidney Int., 47, 1752-1759.
30. KEYSE SM AND TYRRELL RM. (1990). Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365nm) radiation: Evidence for the involvement of the hydroxy radical. Carcinogenesis, 11, 787-791.
31. KLATT P, SCHMIDT K AND MAYER B. (1992). Brain nitric oxide is a haemoprotein. Biochem. J., 288, 15-17.
32. KLEMPT ND, SIRIMANNE E, GUNN AJ, KLEMPT M, SINGH K, WILLIAMS C AND GLUCKMAN PD. (1992). Hypoxia-ischemia induces transforming growth factor β 1 messenger RNA in the infant rat brain. Mol. Brain Res., 13, 93-101.
33. KOONG AC, CHEN EY AND GIACCIA AJ. (1994). Hypoxia causes the activation of nuclear factor κB through phosphorylation of IκBα on tyrosine residues. Cancer Res., 54, 1425-1430.
34. KUWABARA K, OGAWA S, MATSUMOTO M, KOGA S, CLAUSS M, PINSKY DJ, LYN P, LEAVY J, WITTE L, JOSEPH-SILVERSTEIN J, FURIE MB, TORCIA G, COZZOLINO F, KAMADA T AND STERN DM. (1995). Hypoxia-mediated induction of acidic, basic fibroblast growth factor and platelat-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl Acad. Sci. USA, 92, 4606-4610.
35. LADEROUTE KR, GRANT TD, MURPHY BJ AND SUTHERLAND RM. (1992a). Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int. J. Cancer, 52, 428-432.
36. LADEROUTE KR, MURPHY BJ, SHORT SM, GRANT TD, KNAPP AM AND SUTHERLAND RM. (1992b). Enhancement of transforming growth factor-α synthesis in multicellular tumour spheroids of A431 squamous carcinoma cells. Br. J. Cancer, 65, 157-162.
37. LADOUX A AND FRELIN C. (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart, Biochem. Biophys. Res. Commun., 195, 1005-1010.
38. LAVROVSKY Y, SCHWARTZBAUM ML, LEVERE RD, KAPPAS A AND ABRAHAM NG. (1994). Identification of binding sites for the transcription factor NF-κB and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl Acad. Sci. USA, 91, 5987-5991.
39. LEEHUANG S, LIN JJ, KUNG HF, HUANG PL, LEE L AND HUANG PL. (1993). The 3′ flanking region of the human erythropoietin-encoding gene contains nitrogen-regulatory oxygen-sensing consensus sequences and tissue-specific transcriptional regulatory elements. Gene, 137, 203-210.
40. LEFEBVRE V AND BUCCALDERON P. (1995). Deferral prevents against cell lysis induced by hydrogen peroxide to hypoxic hepatocytes: A role for free iron in hypoxia-mediated cellular injury. Chem. Biol. Int., 94, 37-48.
41. MADAN A AND CURTIN PT. (1993). A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl Acad. Sci. USA, 90, 3928-3932.
42. MADAN A, LIN C, HATCH SL AND CURTIN PT. (1995). Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood, 85, 2735-2741.
43. MINCHENKO A, SALCEDA S, BAUER T AND CARO J. (1994). Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res., 40, 35-39.
44. MUKHOPADHYAY D, TSIOKAS L, ZHOU ZM, FOSTER D, BRUGGE JS AND SUKHATME VP. (1995). Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature, 375, 577-581.
45. MURPHY BJ, LADEROUTE KR, SHORT SM AND SUTHERLAND RM. (1991). The identification of heme oxygenase as a major hypoxic stress protein in chinese hamster ovary cells. Br. J. Cancer, 64, 69-73.
46. OHIGASHI T, BROOKINS J AND FISHER JW. (1993). Interaction of nitric oxide and cyclic guanosine 3′,5′-monophosphate in erythropoietin production. J. Clin. Invest., 92, 1587-1591.
47. OHKAWA F, IKEDA U, KAWASAKI K, KUSANO E, IGARASHI M AND SHIMADA K. (1994). Inhibitory effect of interleukin 6 on vascular smooth muscle contraction. Am. J. Physiol., 266, H898-H902.
48. PALLER MS AND HEDLUND BE. (1994). Extracellular iron chelators protect kidney cells from hypoxia, reoxygenation. Free Rad. Biol. Med., 17, 597-603.
49. PATTERSON AV, BARHAM HM, CHINJE EC, ADAMS GE, HARRIS AL AND STRATFORD IJ. (1995). Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR4233). Br. J. Cancer, 72, 1144-1150.
50. PERKINS ND, SCHMID RM, DUCKETT CS, LEUNG K, RICE NR AND NABEL GJ. (1992). Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl Acad. Sci. USA, 89, 1529-1533.
51. PERKINS ND, EDWARDS NL, DUCKET CS, AGRANOFF AB, SCHMID RM AND NABEL GJ. (1993). A cooperative interaction between NF-κB and Spl is required for HIV-1 enhancer activation. EMBO J., 12, 3551-3558.
52. PLATE KH, BREIER G, FARRELL C AND RISAU W. (1992a). Platelet-derived growth factor receptor-β is induced during tumour development and upregulated during tumour progression in endothelial cells in human gliomas. Lab. Invest., 67, 529-534.
53. PLATE KH, BREIER G, WEICH HA AND RISAU W. (1992b). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848.
54. PLATE KH, BREIER G, MILLAUER B, ULLRICH A AND RISAU W. (1993). Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res., 53, 5822-5827.
55. POHL U AND BUSSE R. (1989). Hypoxia stimulates release of endothelium-derived relaxant factor. Am. J. Physiol. (Heart Circ. Physiol.), 256, H1595-H1600.
56. PRICE BD AND CALDERWOOD SK. (1993). Heat induced transcription from RNA polymerases II and III and HSF binding are coordinately regulated by the products of the heat shock genes. J. Cell Physiol., 153, 392-401.
57. PUGH CW, EBERT BL, EBRAHIM O AND RATCLIFFE PJ. (1994a). Characterisation of functional domains within the mouse erythropoietin 3′ enhancer conveying oxygen-regulated responses in different cell-lines. Biochim. Biophys. Acta 1217, 297-306.
58. PUGH CW, EBERT BL, EBRAHIM O, MAXWELL PH AND RATCLIFFE PJ. (1994b). Analysis of cis-acting sequences required for operation of the erythropoietin 3′ enhancer in different cell lines. Ann. NY Acad. Sci., 718, 31-39.
59. QI Y, JAMINDAR TM AND DAWSON G. (1995). Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J. Neurochem., 64, 2458-2464.
60. ROBERTSON N, HAIGH A, ADAMS GE AND STRATFORD IJ. (1994). Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia. Eur. J. Cancer, 30A, 1013-1019.
61. SEMENZA GL, ROTH PH, FANG H. AND WANG GL. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor I. J. Biol. Chem., 269, 23757-23763.
62. SHIBAHARA S, MULLER RM AND TAGUCHI H. (1987). Transcriptional control of rat heme oxygenase by heat shock. J. Biol. Chem., 262, 12889-12892.
63. SHWEIKI D, ITIN A, SOFFER D AND KESHET E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
64. SHWEIKI D, NEEMAN M, ITIN A AND KESHET E. (1995). Induction of vascular endothelial growth factor expression by hypoxia and glucose deficiency in multicellular spheroids: Implications for tumour angiogenesis. Proc. Natl Acad. Sci. USA, 92, 768-772.
65. STAVRI GT, ZACHARY IC, BASKERVILLE PA, MARTIN JF AND ERUSALIMSKY JD. (1995). Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells - Synergistic interaction with hypoxia. Circulation, 92, 11-14.
66. STOLER DL, ANDERSON GR, RUSSO CA, SPINA AM AND BEERMAN TA. (1992). Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. Cancer Res., 52, 4372-4378.
67. STORCH TG AND TALLEY GD. (1988). Oxygen concentration regulates the proliferative response of human fibroblasts to serum and growth factor. Exp. Cell Res., 175, 317-325.
68. TISCHER E, MITCHELL R, HARTMAN T, SILVA M, GOSPODAROWICZ D, FIDDES JC AND ABRAHAM JA. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266, 11947-11954.
69. TUDOR RM, FLOOR BE AND VOELKEL NF. (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J. Clin. Invest., 95, 1798-1807.
70. ULLRICH A AND SCHLESSINGER J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
71. VAUPEL PW. (1993). Oxygenation of solid tumours. In: Drug Resistance in Oncology, Teicher BA, (ed.) pp. 53-85. Marcel Dekker: New York.
72. WALKER LJ, CRAIG RB, HARRIS AL AND HICKSON ID. (1994). A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res., 22, 4884-4889.
73. WANG GL AND SEMENZA GL. (1993a). Desferrioxamine induces erythropoietin gene-expression and hypoxia-inducible factor-1 DNA-binding activity - Implications for models of hypoxia signal-transduction. Blood, 82, 3610-3615.
74. WANG GL AND SEMENZA GL. (1993b). General involvement of hypoxia-inducible factor-1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA, 90, 4304-4308.
75. WANG GL AND SEMENZA GL. (1993c). Characterization of hypoxia-inducible factor-1 and regulation of DNA-binding activity by hypoxia. J. Biol. Chem., 268, 21513-21518.
76. WANG GL AND SEMENZA GL. (1995). Purification and characterisation of hypoxia inducible factor-1. J. Biol. Chem., 270, 1230-1237.
77. 2 tension. Proc. Natl Acad. Sci. USA, 92, 5510-5514.
78. XUE C, RENGASAMY A, LECRAS TD, KOBERNA PA, DAILEY GC AND JOHNS RA. (1994). Distribution of NOS in normoxic vs. hypoxic rat lung - upregulation of NOS by chronic hypoxia. Am. J. Physiol. (Lung Cell. Mol. Physiol.), 11, L667-L678.
79. YAN SF, TRITTO I, PINSKY D, LIAO H, HUANG J, FULLER G, BRETT J, MAY L AND STERN D. (1995). Induction of interleukin 6(IL-6) by hypoxia in vascular cells central role of the binding site for nuclear factor-IL-6. J. Biol. Chem., 270, 11463-11471.
80. YAO K-S AND O'DWYER PJ. (1995). Involvement of NF-κB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 49, 275-282.
81. YAO KS, XANTHOUDAKIS S, CURRAN T AND O'DWYER PJ. (1994a). Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14, 5997-6003.
82. YAO K-S, CLAYTON M AND O'DWYER PJ. (1994b). Interaction of heat and hypoxia in modulating transcription of DT diaphorase in human colon adenocarcinoma cells. Cell Growth Different., 5, 125-131.